• 1
    Jemal A,Siegel R,Ward E,Murray T,Xu J,Thun MJ. Cancer statistics, 2007. CA: Cancer J Clin. 2007; 57: 4366.
  • 2
    [No authors listed]. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990; 264: 14441450.
  • 3
    Brown ML,Nayfield SG,Shibley LM. Adjuvant therapy for stage III colon cancer: economics returns to research and cost-effectiveness of treatment. J Natl Cancer Inst. 1994; 86: 424430.
  • 4
    Sargent DJ,Goldberg RM,Jacobson SD, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001; 345: 10911097.
  • 5
    National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Colon Cancer. Fort Washington, Penn: National Comprehensive Cancer Network; 2007.
  • 6
    Jessup JM,Stewart A,Greene FL,Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005; 294: 27032711.
  • 7
    McGory ML,Zingmond DS,Sekeris E,Bastani R,Ko CY. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer. Dis Colon Rectum. 2006; 49: 319329.
  • 8
    Ayanian JZ,Zaslavsky AM,Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003; 21: 12931300.
  • 9
    Baldwin LM,Dobie SA,Billingsley K, et al. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst. 2005; 97: 12111220.
  • 10
    Cronin DP,Harlan LC,Potosky AL,Clegg LX,Stevens JL,Mooney MM. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol. 2006; 101: 23082318.
    Direct Link:
  • 11
    Dobie SA,Baldwin LM,Dominitz JA,Matthews B,Billingsley K,Barlow W. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst. 2006; 98: 610619.
  • 12
    Edwards BK,Brown ML,Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005; 97: 14071427.
  • 13
    Gross CP,McAvay GJ,Guo Z,Tinetti ME. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer. 2007; 109: 24102419.
  • 14
    Jessup JM,McGinnis LS,Steele GDJr,Menck HR,Winchester DP. The National Cancer Data Base. Report on colon cancer. Cancer. 1996; 78: 918926.
  • 15
    Luo R,Giordano SH,Freeman JL,Zhang D,Goodwin JS. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. Oncologist. 2006; 11: 10251033.
  • 16
    Luo R,Giordano SH,Zhang DD,Freeman J,Goodwin JS. The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist. Cancer. 2007; 109: 975982.
  • 17
    Mahoney T,Kuo YH,Topilow A,Davis JM. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Arch Surg. 2000; 135: 182185.
  • 18
    Neugut AI,Fleischauer AT,Sundararajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol. 2002; 20: 26432650.
  • 19
    Potosky AL,Harlan LC,Kaplan RS,Johnson KA,Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002; 20: 11921202.
  • 20
    Schrag D,Cramer LD,Bach PB,Cohen AM,Warren JL,Begg CB. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA. 2000; 284: 30283035.
  • 21
    Schrag D,Cramer LD,Bach PB,Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001; 93: 850857.
  • 22
    Sundararajan V,Grann VR,Jacobson JS,Ahsan H,Neugut AI. Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study. Cancer J. 2001; 7: 213218.
  • 23
    Sundararajan V,Mitra N,Jacobson JS,Grann VR,Heitjan DF,Neugut AI. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med. 2002; 136: 349357.
  • 24
    VanEenwyk J,Campo JS,Ossiander EM. Socioeconomic and demographic disparities in treatment for carcinomas of the colon and rectum. Cancer. 2002; 95: 3946.
  • 25
    Wu X,Chen VW,Andrews PA,Chen L,Hsieh M,Fontham ET. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana. J La State Med Soc. 2004; 156: 255261.
  • 26
    Abraham NS,Gossey JT,Davila JA,Al-Oudat S,Kramer JK. Receipt of recommended therapy by patients with advanced colorectal cancer. Am J Gastroenterol. 2006; 101: 13201328.
    Direct Link:
  • 27
    Tropman SE,Hatzell T,Paskett E,Ricketts T,Cooper MR,Aldrich T. Colon cancer treatment in rural North and South Carolina. Cancer Detect Prev. 1999; 23: 428434.
  • 28
    Bickell NA,McEvoy MD. Physicians' reasons for failing to deliver effective breast cancer care: a framework for underuse. Med Care. 2003; 41: 442446.
  • 29
    Battaglia TA,Roloff K,Posner MA,Freund KM. Improving follow-up to abnormal breast cancer screening in an urban population. A patient navigation intervention. Cancer. 2007; 109( 2 suppl): 359367.
  • 30
    Steinberg ML,Fremont A,Khan DC, et al. Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges. Cancer. 2006; 107: 26692677.
  • 31
    Aschele C,Guglielmi A,Tixi LM, et al. Adjuvant treatment of colorectal cancer in the elderly. Cancer Control. 1995; 2: 3638.
  • 32
    Au HJ,Mulder KE,Fields AL. Systematic review of management of colorectal cancer in elderly patients. Clin Colorectal Cancer. 2003; 3: 165171.
  • 33
    Fata F,Mirza A,Wood GC, et al. Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center. Cancer. 2002; 94: 19311938.
  • 34
    Kohne CH,Grothey A,Bokemeyer C,Bontke N,Aapro M. Chemotherapy in elderly patients with colorectal cancer. Ann Oncol. 2001; 12: 435442.
  • 35
    Kutner JS,Vu KO,Prindiville SA,Byers TE. Patient age and cancer treatment decisions. Patient and physician views. Cancer Pract. 2000; 8: 114119.
  • 36
    Popescu RA,Norman A,Ross PJ,Parikh B,Cunningham D. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol. 1999; 17: 24122418.
  • 37
    Hodgson DC,Fuchs CS,Ayanian JZ. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst. 2001; 93: 501515.